Organoids overcome the limitations of traditional 2D cell culture models by enabling more physiologically relevant experiments in a 3D, multicellular environment. In particular, utilizing both tumor and normal organoids allows for rapid and precise evaluation of drug specificity, efficacy, and toxicity.
Due to their structural similarity to actual tissues, organoids provide a more realistic platform for research. This makes them highly promising not only for drug development but also for personalized medicine and precision healthcare applications.